Conatus Pharmaceuticals CEO Steven Mento's 2020 pay slips 5% to $1.3M
Conatus Pharmaceuticals reports 2020 executive compensation
By ExecPay News
Published: April 15, 2021
Conatus Pharmaceuticals reported fiscal year 2020 executive compensation information on April 15, 2021.
In 2020, four executives at Conatus Pharmaceuticals received on average a compensation package of $694K, a 44% decrease compared to previous year.
Average pay of disclosed executives at Conatus Pharmaceuticals
Steven J. Mento, Chief Executive Officer, received $1.3M in total, which decreased by 5% compared to 2019.
Susan A. Knudson, Chief Financial Officer, received a compensation package of $624K. 61% of the compensation package, or $380K, was in option awards.
Richard W. Pascoe, Chief Executive Officer, earned $540K in 2020, a 74% decrease compared to previous year.
Gail K. Naughton, Chief Scientific Officer, received $331K in 2020, which increases by 16% compared to 2019.
Related executives
You may also like
Source: SEC filing on April 15, 2021.